ProShare Advisors
OMIC

ProShare Advisors’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

ProShare Advisors’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-404
Closed -$30K – 1898
2022
Q3 		$30K Buy
404
+12
+3% +$1.25K ﹤0.01% 1703
2022
Q2 		$45K Sell
392
-151
-28% -$17.7K ﹤0.01% 1715
2022
Q1 		$103K Buy
543
+117
+27% +$27.1K ﹤0.01% 2026
2021
Q4 		$148K Buy
+426
New +$165K ﹤0.01% 2131

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors's OMIC Position: Q4 2022 in Review

ProShare Advisors sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2022, closing a stake of 404 shares — an estimated $30K sold.

ProShare Advisors first reported a position in OMIC in Q4 2021 and held it in 4 quarters. The position peaked at $148K in Q4 2021. 80 funds tracked by Wall St. Rank hold OMIC as of Q4 2022.

  • ProShare Advisors reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • ProShare Advisors sold 404 Singular Genomics Systems, Inc. Common Stock shares in Q4 2022, an estimated $30K.
  • ProShare Advisors first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • ProShare Advisors's Singular Genomics Systems, Inc. Common Stock position peaked at $148K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2022.

Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.